The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Epstein–Barr virus: more than 50 years old and still providing surprises
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cai, L., Ye, Y., Jiang, Q., Chen, Y., Lyu, X., Li, J., Wang, S., Liu, T., Cai, H., Yao, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms8353 · Cited by 213
RetractedComprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
miRBase: annotating high confidence microRNAs using deep sequencing data
Kozomara, A., & Griffiths-Jones, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1181 · Cited by 5,073
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Self-citationDNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Identification of Virus-Encoded MicroRNAs
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., et al. (2004) · Science · doi:10.1126/science.1096781 · Cited by 1,621
Immunofluorescence in Cells Derived from Burkitt's Lymphoma
Henle, G., & Henle, W. (1966) · Journal of Bacteriology · doi:10.1128/jb.91.3.1248-1256.1966 · Cited by 1,439
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
HAUSEN, H. Z., SCHULTE-HOLTHAUSEN, H., KLEIN, G., HENLE, W., HENLE, G., CLIFFORD, P., & SANTESSON, L. (1970) · Nature · doi:10.1038/2281056a0 · Cited by 1,254
Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M., Ho, M., Griffith, B. P., Hakala, T. R., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90994-2 · Cited by 1,234
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Wang, K., Yuen, S. T., Xu, J., Lee, S. P., Yan, H. H. N., Shi, S. T., Siu, H. C., Deng, S., Chu, K. M., Law, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2983 · Cited by 1,045
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's Disease
Weiss, L. M., Movahed, L. A., Warnke, R. A., & Sklar, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200806 · Cited by 886
Zech, L., Haglund, U., Nilsson, K., & Klein, G. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170108 · Cited by 848
EBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
Heslop, H. E., Ng, C. Y. C., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K., & Rooney, C. M. (1996) · Nature Medicine · doi:10.1038/nm0596-551 · Cited by 821
Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132502 · Cited by 805
Herpesvirus latency confers symbiotic protection from bacterial infection
Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L., & Virgin, H. W. (2007) · Nature · doi:10.1038/nature05762 · Cited by 763
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Au, W.-Y., Weisenburger, D. D., Intragumtornchai, T., Nakamura, S., Kim, W.-S., Sng, I., Vose, J., Armitage, J. O., Liang, R., & for the International Peripheral T-Cell Lymphoma Project (2009) · Blood · doi:10.1182/blood-2008-10-185256 · Cited by 736
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
Self-citationKüppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., & Hansmann, M. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10962 · Cited by 672
Persisting oncogenic herpesvirus induced by the tumour promoter TPA
HAUSEN, H. Z., O'NEILL, F. J., FREESE, U. K., & HECKER, E. (1978) · Nature · doi:10.1038/272373a0 · Cited by 629
Marker Band in One Chromosome 14 from Burkitt Lymphomas
MANOLOV, G., & MANOLOVA, Y. (1972) · Nature · doi:10.1038/237033a0 · Cited by 627
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
de-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., et al. (1978) · Nature · doi:10.1038/274756a0 · Cited by 613
Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., & Rickinson, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8479 · Cited by 600
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
Henle, W., Diehl, V., Kohn, G., zur Hausen, H., & Henle, G. (1967) · Science · doi:10.1126/science.157.3792.1064 · Cited by 588
Dojcinov, S. D., Venkataraman, G., Raffeld, M., Pittaluga, S., & Jaffe, E. S. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf8622 · Cited by 571
Functional role for c-myc in mitogenic response to platelet-derived growth factor
Armelin, H. A., Armelin, M. C. S., Kelly, K., Stewart, T., Leder, P., Cochran, B. H., & Stiles, C. D. (1984) · Nature · doi:10.1038/310655a0 · Cited by 565
Epstein–Barr virus and oncogenesis: from latent genes to tumours
Young, L. S., & Murray, P. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206556 · Cited by 556
Self-citationX-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)
Purtilo, D., Yang, J. S., Cassel, C., Harper, R., Stephenson, S., Landing, B., & Vawter, G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92004-8 · Cited by 553
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Epstein-Barr virus-associated gastric adenocarcinoma
Danilova, N. V., Malkov, P. G., Oleynikova, N. A., & Mikhailov, I. A. (2019) · Arkhiv patologii · doi:10.17116/patol20198103174 · Cited by 516
Bollard, C. M., Gottschalk, S., Torrano, V., Diouf, O., Ku, S., Hazrat, Y., Carrum, G., Ramos, C., Fayad, L., Shpall, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5304 · Cited by 503
Murphy, G., Pfeiffer, R., Camargo, M. C., & Rabkin, C. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.001 · Cited by 500
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4084-4092.1990 · Cited by 497
Self-citationEpidemiology of Hodgkin's Disease
(1973) · The Lancet · doi:10.1016/s0140-6736(73)92483-5 · Cited by 482
Babcock, G. J., Hochberg, D., & Thorley‐Lawson, D. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00049-2 · Cited by 481
Brooks, L., Yao, Q. Y., Rickinson, A. B., & Young, L. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2689-2697.1992 · Cited by 480
Self-citationEpstein-Barr virus-associated gastric adenocarcinoma.
Shibata, D. K., & Weiss, L. M. (1992) · PubMed · Cited by 474
Pope, J. H., Horne, M. K., & Scott, W. M. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030619 · Cited by 472
Malignant lymphomas in transplantation patients.
Penn, I., Hammond, W., BRETTSCHNEIDER, L., & Starzl, T. E. (1969) · PubMed · Cited by 469
Latent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor molecule
Gires, O. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6131 · Cited by 451
Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E., & Osato, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9131 · Cited by 445
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups 2
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.5.1147 · Cited by 415
Lo, Y. M. D., Chan, L. Y. S., Chan, A. T. �., Leung, S. F., Lo, K. W., Zhang, J., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 390
Tomkinson, B., Robertson, E., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2014-2025.1993 · Cited by 388
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh, T., Hennessy, K., Chamnankit, L., & Kieff, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7632 · Cited by 383
Rickinson, A. B., Young, L. S., & Rowe, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1310-1317.1987 · Cited by 369
Self-citationThe genomic landscape of nasopharyngeal carcinoma
Lin, D.-C., Meng, X., Hazawa, M., Nagata, Y., Varela, A. M., Xu, L., Sato, Y., Liu, L.-Z., Ding, L.-W., Sharma, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3006 · Cited by 366
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Narpala, S., Todd, J.-P., Rao, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.043 · Cited by 366
Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., & Young, L. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.339 · Cited by 356
Self-citationDawson, C. W., Port, R. J., & Young, L. S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.004 · Cited by 355
Self-citationClose link between reduction of c-myc expression by interferon and G0/G1 arrest
Einat, M., Resnitzky, D., & Kimchi, A. (1985) · Nature · doi:10.1038/313597a0 · Cited by 353
Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes
Rowe, M., Lear, A. L., Croom-Carter, D., Davies, A. H., & Rickinson, A. B. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.122-131.1992 · Cited by 351
Transcriptional activation of the translocated c- myc oncogene in Burkitt lymphoma
Erikson, J., Ar-Rushdi, A., Drwinga, H. L., Nowell, P. C., & Croce, C. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.820 · Cited by 342
The role of Epstein–Barr virus in epithelial malignancies
Tsao, S., Tsang, C. M., To, K., & Lo, K. (2015) · The Journal of Pathology · doi:10.1002/path.4448 · Cited by 337
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Imai, S., Nishikawa, J., & Takada, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4371-4378.1998 · Cited by 324
Epidemiologic patterns of Hodgkin's Disease
Correa, P., & O'Conor, G. T. (1971) · International Journal of Cancer · doi:10.1002/ijc.2910080203 · Cited by 298
X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery
Seemayer, T. A., Gross, T. G., Egeler, R. M., Pirruccello, S. J., Davis, J. R., Kelly, C. M., Okano, M., Lanyi, A., & Sumegi, J. (1995) · Pediatric Research · doi:10.1203/00006450-199510000-00001 · Cited by 297
Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., & Takada, K. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6069-6073.1994 · Cited by 291
Geographical prevalence of two types of Epstein-Barr virus
Zimber, U., Adldinger, H. K., Lenoir, G. M., Vuillaume, M., Knebel-Doeberitz, M. V., Laux, G., Des̀granges, C., Wittmann, P., Freese, U.-K., Schneider, U., et al. (1986) · Virology · doi:10.1016/0042-6822(86)90429-0 · Cited by 290
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
Thorley-Lawson, D. A., & Allday, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro2015 · Cited by 282
Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., et al. (1988) · Nature · doi:10.1038/333455a0 · Cited by 281
T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria
Whittle, H. C., Brown, J., Marsh, K., Greenwood, B. M., Seidelin, P., Tighe, H., & Wedderburn, L. (1984) · Nature · doi:10.1038/312449a0 · Cited by 278
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
Kennedy, G., Komano, J., & Sugden, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336099100 · Cited by 276
Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease
Wu, T., Mann, R. B., Charache, P., Hayward, S. D., Staal, S., Lambe, B. C., & Ambinder, R. F. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460509 · Cited by 275
Genetic and epigenetic changes in nasopharyngeal carcinoma
Lo, K.-W., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000883 · Cited by 269
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
Komano, J. A., Maruo, S., Kurozumi, K., Oda, T., & Takada, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9827-9831.1999 · Cited by 268
Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection
Palser, A. L., Grayson, N. E., White, R. E., Corton, C., Correia, S., Ba abdullah, M. M., Watson, S. J., Cotten, M., Arrand, J. R., Murray, P. G., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03614-14 · Cited by 260
Self-citationMARROW TRANSPLANTATION FOR THALASSAEMIA FOLLOWING BUSULPHAN AND CYCLOPHOSPHAMIDE
Lucarelli, G. T. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91784-2 · Cited by 258
POST-PARTUM PULMONARY ŒDEMA ASSOCIATED WITH PREVENTIVE THERAPY FOR PREMATURE LABOUR
Tinga, D. J., Aarnoudse, J. G., Rogge, P., Young, S., & Goodlin, R. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92772-7 · Cited by 257
Lee, J., Kim, S., Han, S., An, J., Lee, E., & Kim, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05775.x · Cited by 256
Gruhne, B., Sompallae, R., Marescotti, D., Kamranvar, S. A., Gastaldello, S., & Masucci, M. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810619106 · Cited by 252
Pyothorax-Associated Lymphoma: A Review of 106 Cases
Nakatsuka, S.-I., Yao, M., Hoshida, Y., Yamamoto, S., Iuchi, K., & Aozasa, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.021 · Cited by 245
Rowe, M., Glaunsinger, B., van Leeuwen, D., Zuo, J., Sweetman, D., Ganem, D., Middeldorp, J., Wiertz, E. J. H. J., & Ressing, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611128104 · Cited by 240
Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
Khan, G., & Hashim, M. J. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-38 · Cited by 240
Tsai, M., Raykova, A., Klinke, O. K., Bernhardt, K., Gärtner, K., Leung, C. S. K., Geletneky, K., Sertel, S., Münz, C., Feederle, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.012 · Cited by 232
Kelly, G., Bell, A., & Rickinson, A. (2002) · Nature Medicine · doi:10.1038/nm758 · Cited by 228
EBV-Infected B Cells in Infectious Mononucleosis
Kurth, J., Spieker, T., Wustrow, J., Strickler, J. G., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · Immunity · doi:10.1016/s1074-7613(00)00048-0 · Cited by 226
Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13993-14003.2005 · Cited by 225
Lo, K.-W., Chung, G. T.-Y., & To, K.-F. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.011 · Cited by 220
Clonal transformation of adult human leukocytes by Epstein-Barr virus
Sugden, B., & Mark, W. (1977) · Journal of Virology · doi:10.1128/jvi.23.3.503-508.1977 · Cited by 211
Hui, E. P., Taylor, G. S., Jia, H., Ma, B. B. Y., Chan, S. L., Ho, R., Wong, W.-L., Wilson, S., Johnson, B. F., Edwards, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2448 · Cited by 207
Efficiency of transformation of lymphocytes by Epstein-Barr virus
Henderson, E., Miller, G., Robinson, J., & Heston, L. (1977) · Virology · doi:10.1016/0042-6822(77)90292-6 · Cited by 205
Zuo, J., Currin, A., Griffin, B. D., Shannon-Lowe, C., Thomas, W. A., Ressing, M. E., Wiertz, E. J. H. J., & Rowe, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000255 · Cited by 204
Rescue of “crippled” germinal center B cells from apoptosis by Epstein-Barr virus
Mancao, C., Altmann, M., Jungnickel, B., & Hammerschmidt, W. (2005) · Blood · doi:10.1182/blood-2005-06-2341 · Cited by 203
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
Bräuninger, A., Schmitz, R., Bechtel, D., Renné, C., Hansmann, M., & Küppers, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21716 · Cited by 202
Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Mutirangura, A., Pornthanakasem, W., Theamboonlers, A., Sriuranpong, V., Lertsanguansinchi, P., Yenrudi, S., Voravud, N., Supiyaphun, P., & Poovorawan, Y. (1998) · PubMed · Cited by 197
Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye
Rabson, M. S., Gradoville, L., Heston, L., & Miller, G. (1982) · Journal of Virology · doi:10.1128/jvi.44.3.834-844.1982 · Cited by 197
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome
Bhende, P. M., Seaman, W. T., Delecluse, H.-J., & Kenney, S. C. (2004) · Nature Genetics · doi:10.1038/ng1424 · Cited by 192
Taylor, G. S., Jia, H., Harrington, K., Lee, L. W., Turner, J., Ladell, K., Price, D. A., Tanday, M., Matthews, J., Roberts, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1122-t · Cited by 189
Hislop, A. D., Ressing, M. E., van Leeuwen, D., Pudney, V. A., Horst, D., Koppers-Lalic, D., Croft, N. P., Neefjes, J. J., Rickinson, A. B., & Wiertz, E. J. H. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070256 · Cited by 189
Anderton, E., Yee, J., Smith, P., Crook, T., White, R. E., & Allday, M. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210668 · Cited by 185
Non-viral environmental risk factors for nasopharyngeal carcinoma: A systematic review
Jia, W.-H., & Qin, H.-D. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.009 · Cited by 185
Pearson, G. R., Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun, D., & Kieff, E. (1987) · Virology · doi:10.1016/0042-6822(87)90055-9 · Cited by 183
Longnecker, R., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2319-2326.1990 · Cited by 178
Niedobitek, G., Hansmann, M. L., Herbst, H., Young, L. S., Dienemann, D., Hartmann, C.-A., Finn, T., Pitteroff, S., Welt, A., Anagnostopoulos, I., et al. (1991) · The Journal of Pathology · doi:10.1002/path.1711650105 · Cited by 177
Self-citationKelly, G. L., Long, H. M., Stylianou, J., Thomas, W. A., Leese, A., Bell, A. I., Bornkamm, G. W., Mautner, J., Rickinson, A. B., & Rowe, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000341 · Cited by 177
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C., & Moss, D. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.345 · Cited by 170
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C., Gribben, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58092 · Cited by 166
Self-citationNg, S., Selvarajan, V., Huang, G., Zhou, J., Feldman, A. L., Law, M., Kwong, Y., Shimizu, N., Kagami, Y., Aozasa, K., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2823 · Cited by 161
Diepstra, A., Niens, M., Vellenga, E., van Imhoff, G., Nolte, I., Schaapveld, M., van der Steege, G., van den Berg, A., Kibbelaar, R., te Meerman, G., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66780-3 · Cited by 161
Wong, A. M., Kong, K. L., Tsang, J. W. H., Kwong, D. L. �., & Guan, X. (2011) · Cancer · doi:10.1002/cncr.26309 · Cited by 160
Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M. Y., Takada, K., Lui, V. W. Y., Lung, M. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202637109 · Cited by 159
Insights into B cells and HIV ‐specific B‐cell responses in HIV ‐infected individuals
Moir, S. L., & Fauci, A. S. (2013) · Immunological Reviews · doi:10.1111/imr.12067 · Cited by 152
PD-1 Dependent Exhaustion of CD8+ T Cells Drives Chronic Malaria
Horne‐Debets, J. M., Faleiro, R. J., Karunarathne, D. S., Liu, X. Q., Lineburg, K. E., Poh, C. M., Grotenbreg, G. M., Hill, G. R., MacDonald, K. P. A., Good, M. F., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.002 · Cited by 147
Bhende, P. M., Dickerson, S., Sun, X., Feng, W., & Kenney, S. C. (2007) · Journal of Virology · doi:10.1128/jvi.00154-07 · Cited by 141
The genome of Epstein–Barr virus type 2 strain AG876
Dolan, A., Addison, C., Gatherer, D., Davison, A. J., & McGeoch, D. J. (2006) · Virology · doi:10.1016/j.virol.2006.01.015 · Cited by 139
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival
Kang, D., Skalsky, R. L., & Cullen, B. R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004979 · Cited by 137
Shinozaki‐Ushiku, A., Kunita, A., Isogai, M., Hibiya, T., Ushiku, T., Takada, K., & Fukayama, M. (2015) · Journal of Virology · doi:10.1128/jvi.03639-14 · Cited by 135
Establishment of Cell Lines from Peripheral Leucocytes in Infectious Mononucleosis
Pope, J. H. (1967) · Nature · doi:10.1038/216810a0 · Cited by 132
Sun, C. C., & Thorley‐Lawson, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.01055-07 · Cited by 132
Shannon-Lowe, C. D., Adland, E., Bell, A. I., Delecluse, H., Rickinson, A. B., & Rowe, M. (2009) · Journal of Virology · doi:10.1128/jvi.00108-09 · Cited by 129
Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ruf, I. K., Rhyne, P., Yang, H. J., Borza, C. M., Hutt‐Fletcher, L. M., Cleveland, J. L., & Sample, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1651 · Cited by 127
Liu, P., Fang, X., Feng, Z., Guo, Y., Peng, R., Liu, T., Huang, Z., Feng, Y., Sun, X., Xiong, Z., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00823-11 · Cited by 125
Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis
Miettinen, M. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.178 · Cited by 124
de Jesus, O., Smith, P. R., Spender, L. C., Karstegl, C. E., Niller, H. H., Huang, D. P., & Farrell, P. J. (2003) · Journal of General Virology · doi:10.1099/vir.0.19054-0 · Cited by 124
Shannon-Lowe, C. D., & Rowe, M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001338 · Cited by 121
Whole-Genome Sequencing of the Akata and Mutu Epstein-Barr Virus Strains
Lin, Z. N., Wang, X., Strong, M. J., Concha, M., Baddoo, M., Xu, G., Baribault, C., Fewell, C., Hulme, W. F., Hedges, D. J., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02517-12 · Cited by 120
Kwok, H., Wu, C., Palser, A. L., Kellam, P., Sham, P. C., Kwong, D. L. �., & Chiang, A. (2014) · Journal of Virology · doi:10.1128/jvi.01665-14 · Cited by 118
Hislop, A. D., Palendira, U., Leese, A. M., Arkwright, P. D., Rohrlich, P., Tangye, S. G., Gaspar, H. B., Lankester, A. C., Moretta, A., & Rickinson, A. B. (2010) · Blood · doi:10.1182/blood-2009-09-238832 · Cited by 116
The role of miRNAs and EBV BARTs in NPC
Marquitz, A. R., & Raab‐Traub, N. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.001 · Cited by 115
Zhang, G., Zong, J., Lin, S., Verhoeven, R. J. A., Tong, S., Chen, Y., Ji, M., Cheng, W., Tsao, S., Lung, M. L., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29206 · Cited by 114
Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase Complex
Sato, Y., Kamura, T., Shirata, N., Murata, T., Kudoh, A., Iwahori, S., Nakayama, S., Isomura, H., Nishiyama, Y., & Tsurumi, T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000530 · Cited by 114
Seto, E., Yang, L., Middeldorp, J. M., Sheen, T., Chen, J.-Y., Fukayama, M., Eizuru, Y., Ooka, T., & Takada, K. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20327 · Cited by 114
Hsu, C., Yi, Y.-H., Chang, K., Chang, Y., Chen, S., & Chen, H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003974 · Cited by 113
Kelly, G. L., Milner, A. E., Tierney, R. J., Croom-Carter, D. S. G., Altmann, M., Hammerschmidt, W., Bell, A. I., & Rickinson, A. B. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10709-10717.2005 · Cited by 112
A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Torgbor, C., Awuah, P. C., Deitsch, K., Kalantari, P., Duca, K., & Thorley‐Lawson, D. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004170 · Cited by 111
Haas, A., Zimmermann, K., & Oxenius, A. (2011) · Journal of Virology · doi:10.1128/jvi.05607-11 · Cited by 111
Wangrong, W., Iwakiri, D., Yamamoto, K., Maruo, S., Kanda, T., & Takada, K. (2006) · Journal of Virology · doi:10.1128/jvi.01416-06 · Cited by 110
Moss, D. J., Burrows, S. R., Castelino, D., Kane, R. G., Pope, J. H., Rickinson, A. B., Alpers, M. P., & Heywood, P. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310609 · Cited by 109
The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes
Feederle, R., Haar, J., Bernhardt, K., Linnstaedt, S. D., Bannert, H., Lips, H., Cullen, B. R., & Delecluse, H. (2011) · Journal of Virology · doi:10.1128/jvi.05100-11 · Cited by 109
p73 gene promoter methylation in Epstein‐Barr virus‐associated gastric carcinoma
Ushiku, T., Chong, J., Uozaki, H., Hino, R., Chang, M., Sudo, M., Rani, B. R., Sakuma, K., Nagai, H., & Fukayama, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22275 · Cited by 106
5-AZACYTIDINE FOR BETA-THALASSAEMIA?
Clegg, J. B., Weatherall, D. J., & Bodmer, W. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92227-4 · Cited by 105
Santpere, G., Darré, F., Blanco, S., Alcamí, A., Villoslada, P., Albà, M. M., & Navarro, A. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu054 · Cited by 105
Njie, R., Bell, A. I., Jia, H., Croom-Carter, D. S. G., Chaganti, S., Hislop, A. D., Whittle, H. C., & Rickinson, A. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/594373 · Cited by 105
A transforming function of the BARF1 gene encoded by Epstein‐Barr virus.
Wei, M., & Ooka, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08438.x · Cited by 103
Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells
Wu, C.-C., Liu, M., Chang, Y., Fang, C., Chou, S., Liao, H.-W., Kuo, K.-L., Hsu, S.-L., Chen, Y.-R., Wang, P., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1169 · Cited by 103
Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells
Rymo, L. (1979) · Journal of Virology · doi:10.1128/jvi.32.1.8-18.1979 · Cited by 98
Kwok, H. F., Tong, A. H. Y., Lin, C. H., Lok, S., Farrell, P. J., Kwong, D. L. �., & Chiang, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036939 · Cited by 93
Yang, X., Dai, W., Kwong, D. L. �., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29192 · Cited by 91
The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo
Qiu, J. J., Smith, P., Leahy, L., & Thorley‐Lawson, D. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004561 · Cited by 89
Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis
Takada, K. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.007 · Cited by 88
EBV-Related Lymphomas: New Approaches to Treatment
Kanakry, J. A., & Ambinder, R. F. (2013) · Current Treatment Options in Oncology · doi:10.1007/s11864-013-0231-y · Cited by 84
Roughan, J. E., Torgbor, C., & Thorley‐Lawson, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.01780-09 · Cited by 84
Hausen, A. Z., van Rees, B. P., van Beek, J., Craanen, M. E., Bloemena, E., Offerhaus, G. J. A., Meijer, C. J. L. M., & van den Brule, A. J. C. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014068 · Cited by 80
Tierney, R. J., Shannon-Lowe, C. D., Fitzsimmons, L., et al. (2014) · Virology · doi:10.1016/j.virol.2014.10.030 · Cited by 79
Apoptosis in Burkitt lymphoma cells is driven by c-myc.
Milner, A. E., Grand, R. J. A., Waters, C. M., & Gregory, C. D. (1993) · PubMed · Cited by 77
Kanda, T., Furuse, Y., Oshitani, H., & Kiyono, T. (2016) · Journal of Virology · doi:10.1128/jvi.00060-16 · Cited by 75
Alber, G., Kim, K.-M., Weiser, P., Riesterer, C., Carsetti, R., & Reth, M. G. (1993) · Current Biology · doi:10.1016/0960-9822(93)90196-u · Cited by 68
Epstein–Barr virus and multiple sclerosis. From evidence to therapeutic strategies
Menéndez, S. F., Fernández-Morán, M., Fernández‐Vega, I., Pérez-Álvarez, Á. I., & Villafani, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.013 · Cited by 68
Panagopoulos, D., Victoratos, P., Alexiou, M. V., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13253-13261.2004 · Cited by 66
Jochner, N., Eick, D., Zimber‐Strobl, U., Pawlita, M., Bornkamm, G. W., & Kempkes, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00367.x · Cited by 64
Chang, Y.-H., Lee, C., Su, M.-T., Wang, J.-T., Chen, J., Lin, S., Tsai, C.-H. A., Hsieh, M.-J., Takada, K., & Chen, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039217 · Cited by 64
Sheu, L., Chen, A., Meng, C., et al. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90078-2 · Cited by 63
Optimal treatment for chronic active Epstein–Barr virus disease
Cohen, J. I. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2008.01095.x · Cited by 59
Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cells
Pajic, A., Staege, M. S., Dudziak, D., Schuhmacher, M., Spitkovsky, D. D., Eissner, G., Brielmeier, M., Polack, A., & Bornkamm, G. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.1404 · Cited by 58
Zhang, C. X., Decaussin, G., DAILLIE, J., & Ooka, T. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.1862-1869.1988 · Cited by 52
Lin, Z. N., Xu, G., Deng, N., Taylor, C. M., Zhu, D., & Flemington, E. K. (2010) · Journal of Virology · doi:10.1128/jvi.01521-10 · Cited by 48
Gianti, E., Messick, T. E., Lieberman, P. M., & Zauhar, R. J. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9899-y · Cited by 43
Ni, C., Chen, Y., Zeng, M., Pei, R., Du, Y., Tang, L., Wang, M., Hu, Y., Zhu, H., He, M., et al. (2015) · Cell Research · doi:10.1038/cr.2015.50 · Cited by 42
Watanabe, A., Maruo, S., Ito, T., Ito, M., Katsumura, K. R., & Takada, K. (2009) · Journal of Virology · doi:10.1128/jvi.01616-09 · Cited by 39
Non-human Primate Lymphocryptoviruses: Past, Present, and Future
Mühe, J., & Wang, F. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_13 · Cited by 26
Li, L., Zhang, Y., Guo, B. B., Chan, F. K. L., & Tao, Q. (2014) · 癌症:英文版 · doi:10.5732/cjc.014.10191 · Cited by 25
Chang, J. T.-C., Liao, C.-T., Jung, S.-M., Wang, T.-C. V., See, L.-C., & Cheng, A.-J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1194 · Cited by 20
Cited by
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
Nasopharyngeal carcinoma: an evolving paradigm
Wong, K. C. W., Hui, E. P., Lo, K.-W., Lam, W. K. J., Johnson, D., Li, L., Tao, Q., Chan, K. C. A., To, K.-F., King, A. D., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00524-x · Cited by 546
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
Chen, Y.-P., Yin, J.-H., Li, W.-F., Li, H.-J., Chen, D.-P., Zhang, C.-J., Lv, J.-W., Wang, Y.-Q., Li, X.-M., Li, J.-Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0374-x · Cited by 463
Metadata
- Authors
- Young, L. S., Yap, L. F., & Murray, P. G.
- Venue
- Nature Reviews Cancer
- Published
- 2016-09-30
- Volume
- 16
- Issue
- 12
- Pages
- 789-802
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2526219494
- Cited by
- 856
- References
- 182
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.